Furthermore, adiponectin expression blunts increases in insulin, TNF-α, endothelin-1, and glucocorticoids, factors implicated in the pathogenesis of insulin resistance, subclinical inflammation, endothelial dysfunction, and regulation of energy metabolism, and closely related to the development of MS, DM2, and cardiovascular disease (21). Here, ADIPOQ is linked to myeloid sarcoma.